Altimmune appointed Richard Menziuso as Vice President, Global Controller and Principal Accounting Officer effective September 29, 2026. Menziuso brings 28 years of finance experience, including roles at Centessa Pharmaceuticals, Thermo Fisher Scientific, and Axovant Gene Therapies. Gregory Weaver remains Chief Financial Officer. The biopharmaceutical company develops therapies for infectious diseases and metabolic disorders.
